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Abstract  The  aim  of  this  report  is  to  describe  a  rare  case  of  necrotizing  pneumonia  due  to
group B  Streptococcus  serotype  III  in  a  relatively  young  male  adult  (48  years  old)  suffering  from
diabetes. The  organism  was  isolated  from  his  pleural  fluid  and  was  only  resistant  to  tetracycline.
The patient  first  received  ceftazidime  (2  g/8  h  i.v.)  +  clindamycin  (300  mg/8  h)  for  18  days  and
then he  was  discharged  home  and  orally  treated  with  amoxicillin  clavulanic  acid  (1  g/12  h) for
23 days  with  an  uneventful  evolution.  As  in  the  cases  of  invasive  infection  by  Streptococcus
pyogenes, clindamycin  could  prevent  streptococcal  toxic  shock  syndrome.
© 2016  Asociacio´n Argentina  de  Microbiolog´ıa.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is an
open access  article  under  the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Resumen  El objetivo  de esta presentación  es  describir  un  caso  raro  de neumonía  necrosante
debida a  estreptococo  del  grupo  B serotipo  iii  en  un diabético  adulto  de sexo  masculino  relativa-
mente joven  (48  an˜os).  El microorganismo  fue aislado  de líquido  pleural  y  resultó  ser  resistente
solo a  tetraciclina.  El  paciente  recibió  ceftacidima  (2  g/8  h  iv)  + clindamicina  (300  mg/8  h)
ado  de alta,  bajo  tratamiento  oral  con  amoxicilina-ácido  clavulánico
Diabetes
durante 18  días  y  luego  fue  d∗ Corresponding author.
E-mail address: hlopar25@gmail.com (H. Lopardo).
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BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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(1 g/12  h).  Este  tratamiento  se  mantuvo  durante  23  días,  con  buena  evolución.  Como  en  casos  de
infecciones invasivas  por  Streptococcus  pyogenes,  es  posible  que  la  clindamicina  haya  evitado
la aparición  del  síndrome  de shock  tóxico  estreptocócico.
©  2016  Asociacio´n Argentina  de Microbiolog´ıa.  Publicado  por  Elsevier  Espan˜a,  S.L.U.  Este  es  un
art´ıculo Open  Access  bajo  la  licencia  CC BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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dosing  convenience  and  the  possibility  of  the presence
of  non-detected  anaerobic  bacteria,  taking  into  account
that  it was  a necrotizing  pneumonia.Group  B  streptococcal  (GBS)  invasive diseases  have sig-
ificantly  increased  during  the  past  two  decades  among
onpregnant  adults,  especially  among  those  with  underlying
edical  conditions  or  advanced  age8. Most  cases  of inva-
ive  GBS disease  occur  among elderly  non-pregnant  adults,
ith  a case-fatality  rate  greater  than  10%, exceeding  that  in
nfants  (3--5%).  Approximately  one-half  of the deaths  from
nvasive  GBS  disease  in  the  United  States  occur  among  adults
5  years  of  age2,5,7.
Pneumonia  due  to  GBS is  most  often  encountered  in
lderly  people  rather  than  in younger  adults.  Diabetes  melli-
us  is  a  risk  factor  for developing  GBS infections  as  a whole6.
he  aim  of  this report  is  to  describe  a case  of necrotizing
neumonia  due  to  GBS  in a young  male  adult  (<65  years  of
ge)  suffering  from  diabetes.
A 48-years-old  man  with  dyspnea  (functional  class  IV),
ight  sweats,  nonproductive  cough,  fever  (39 ◦C), and
eight  loss  was  admitted  to  the emergency  room  of a hos-
ital  in La Plata  City.  He  was  referred  to  our  hospital  for
urgical  evaluation.
The  patient  had  been  suffering  from  a  right-side  back
ain  for  over  a month.  Blood  pressure  was  110/80  mmHg,
is  heart  rate  was  120/min,  and  respiratory  frequency  was
6/min.  Serum  potassium  level  was  4.1  mEq/dl.  WBC count
as  17700/mm3,  and  plasma  glucose  was  254 mg/dl.  A  pre-
iously  unknown  type 2  diabetes  was  diagnosed.
An  empyema  was  observed  in  the right  lower  lobe  by  a
hest  radiograph  (Fig.  1)  and  by  computerized  axial  tomo-
raphy  (Fig.  2).The  patient  was  taken  to  the  operating  room  where
ecortication  and  atypical  lung  resection  were  performed.
n  empyema  and  lung  necrosis  were observed.  Samples  of
igure  1  Chest  radiograph.  Alveolar  pattern  in the  lower  third
f right  lung  (arrow  1)  and  blunting  of  the  right  costophrenic
ngle  (arrow  2).
F
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(
lucopurulent  pleural  fluid,  pleural  biopsy  and pulmonary
arenchyma  were  obtained  and  three  drainage  tubes  were
eft at the  site.  Pleural  fluid  contained  neutrophils,  histi-
cytes  but  no  neoplastic  cells.  The  pleural  biopsy  showed
ell  debris,  fibrinoid  necrosis  and granulation  tissue.  The
ulmonary  parenchyma  also  showed  inflammatory  cells  and
ranulation  tissue  compatible  with  a lung  abscess  in way  of
rganization.
GBS  serotype  III  was  isolated  from  the pleural  fluid
ultured  in blood  agar  and  chocolate  agar  plates.  Based
n  Vitek  2  (bio Mérieux  Argentina)  results,  it was  sus-
eptible  to  ampicillin  (MIC  = 0.25  mg/ml),  erythromycin
MIC  =  0.25  mg/ml),  clindamycin  (MIC  =  0.25  mg/ml)  and van-
omycin  (MIC  = 0.5 mg/ml)  but  resistant  to  tretracycline
≥16  mg/ml).
The  patient  first  received  ceftazidime  (2 g/8  h
.v.)  +  clindamycin  (300  mg/8  h)  for  18  days  and  then  he
as  discharged  home  and  orally  treated  with  amoxicillin--
lavulanic  acid  (1  g/12  h)  for  23  days  with  an uneventful
volution.
The  use  of  ceftazidime  + clindamycin  was  indicated
espite  not being  the elective  option  for  community-
cquired  pneumonia.  As it  was  effective  in improving  the
atient’s  condition,  it was  not  changed  to  another  scheme
overing  a  reduced  spectrum.  Amoxicillin-clavulanic  acid
as  the antibiotic  of  choice  for  oral  treatment  because  ofigure  2 Computer  axial  tomography.  Rounded  mass  with
hickened  wall  (arrow  1)  and  heterogeneous  liquid  content
arrow  2)  inside  topography  of  lower  right  lobe  compatible  with
ung abscess.
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8Group  B streptococcal  necrotizing  pneumonia  in  a diabetic  a
Pneumonia  due  to  GBS almost  exclusively  occurs  in  older
debilitated  adults  with  central  nervous  system  dysfunction.
It  is  often  associated  with  health  care  and  results  in high
case-fatality  rate3. Chest  radiographs  reveal  lobar  or  multi-
lobar  infiltrates  that  are not  usually  associated  with  pleural
reactions4,  lung  tissue  necrosis  being  rare9.
The  present  case  occurred  in a 48-years-old  diabetic  man
without  CNS  involvement,  who  survived  after  appropriate
treatment.  Though  concomitant  organisms  are  frequently
found,  GBS was  the  unique  causal agent  in  this case.
In  nonpregnant  adults,  types  Ia,  III,  and  V  account  for
66--83%  of isolates  causing  invasive  infection  in the  United
States1.  The  most  commonly  identified  type in nonpregnant
adults  has  been  serotype  V,  accounting  for  24--31%  of  inva-
sive  isolates1.
In  Argentina,  only  one  study  included  GBS from  nonpreg-
nant  adults  with  invasive  infections6.  Serotypes  II,  Ia/c,
III,  and  IV  were  commonly  found,  with  serotype  II  being
prevalent  in  younger  adults  (18--69  years  old)  and  serotype
Ia/c  being  prevalent  in elderly  adults  (>70  years  old).  GBS
attributable  mortality  assessed  in that  study  was  11.5%,  and
included  a 30-year-old  man suffering  from  AIDS,  pneumonia
and  ascitis,  who  died  suddenly  as  a consequence  of  strepto-
coccal  bacteremia6.
To  conclude,  we  present  this case  to  highlight  the
necrotizing  nature  of  pneumonia  and  the success  of  the
antimicrobial  treatment.  As  in cases  of  invasive  infection  by
Streptococcus  pyogenes,  clindamycin  could  prevent  strep-
tococcal  toxic  shock  syndrome,  since  GBS  may  also  produce
pyrogenic  toxins.
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